AMRX Dividend History & Analysis | Yield
AMRX has a dividend yield of and paid per share in the last 12M. Complete payout history, full analyses and peer comparison.
Top Dividend Payers in Pharmaceuticals
| SYMBOL | MARKET CAP USD | YIELD TTM | YIELD ON COST 5y |
|---|---|---|---|
| SUPN NASDAQ Supernus Pharmaceuticals |
1,523 M | 28.68% | 65.49% |
| BMY NYSE Bristol-Myers Squibb |
127,020 M | 4.38% | 5.24% |
| TAK NYSE Takeda Pharmaceutical |
67,157 M | 3.83% | 6.12% |
| NVS NYSE Novartis |
305,825 M | 3.06% | 6.95% |
| GSK NYSE GSK |
100,885 M | 3.53% | 5.14% |
| NOVN SW Novartis |
309,130 M | 2.99% | 6.19% |
| VTRS NASDAQ Viatris |
21,789 M | 3.50% | 4.10% |
| MRK NYSE Merck |
362,526 M | 2.89% | 4.72% |
| ORNBV HE Orion |
16,067 M | 2.38% | 5.59% |
| RO SW Roche Holding |
394,589 M | 3.26% | 3.17% |
| SYMBOL | MARKET CAP USD | GROWTH RATE | CONSISTENCY |
|---|---|---|---|
| HLUN-B CO H Lundbeck |
8,233 M | 26.64% | 100.0% |
| SECT-B ST Sectra (publ) |
6,295 M | 26.84% | 99.0% |
| FAGR BR Fagron |
1,993 M | 18.76% | 100.0% |
| LLY NYSE Eli Lilly |
1,215,626 M | 15.24% | 100.0% |
| NVS NYSE Novartis |
305,825 M | 8.79% | 100.0% |
| MRK NYSE Merck |
362,526 M | 5.34% | 100.0% |
| RPRX NASDAQ Royalty Pharma |
39,044 M | 5.31% | 100.0% |
| IPN PA Ipsen |
14,410 M | 7.55% | 98.0% |
| JNJ NYSE Johnson & Johnson |
664,947 M | 4.72% | 100.0% |
| NOVN SW Novartis |
309,130 M | 4.53% | 100.0% |
AMRX Dividend History
Dividend Monthly Return EX date, 0 years of data
Average monthly dividend return by ex-dividend date. The score below shows reliability based on how consistently dividends were paid in that month.
AMRX Dividend FAQ
As of November 2026, AMRX's dividend yield is %. This is calculated by dividing the trailing 12-month dividend rate (TTM rate) of - by the current share price of 21.28.
As of November 2026 AMRX does not pay a dividend.
Over the last 12 months, AMRX has issued dividend payments.
Based on historical data, the forecasted dividends per share for AMRX for the next payments are between 0 (+0.0%) and 0 (+0.0%). This suggests the dividend will remain relatively stable. The expected Yield for the next 12 months is about -%.
The next Ex-Dividend date for Amneal Pharmaceuticals (AMRX) is currently unknown.
The next Ex-Dividend date for Amneal Pharmaceuticals (AMRX) is currently unknown. We automatically update the next Ex-Dividend date when it is announced.
AMRX's average dividend growth rate over the past 5 years is -% per year.
AMRX's 5-Year Yield on Cost is -%. If you bought AMRX's shares at 5.26 five years ago, your current annual dividend income (- per share, trailing 12 months) equals -% of your original purchase price.
AMRX Payout Consistency is 0.0%. The payout consistency is a proprietary measure of how consistently a company has paid dividends over its lifetime and blends growth rate, number of dividend payments, interruptions or lowering dividends into one number.
AMRX's % Dividend Yield is considered as unknown.
The Dividend Payout Ratio of AMRX is unknown.
AMRX's Overall Dividend Rating is (unknown). Ratings surpassing 65% are regarded as acceptable, exceeding 75% are favorable and surpassing 85% are strong.
AMRX Outstanding Shares Analysis
Key Metric Definitions
Annual dividend per share divided by current share price.
Percentage of earnings paid as dividends. Below 60% = safe, above 100% = unsustainable.
Percentage of Free Cash Flow paid as dividends. More reliable than Payout Ratio since it measures actual cash.
Compound annual growth rate of dividends over the last 5 years.
Reliability of dividend payments over lifetime. Penalizes cuts and pauses.
Your effective yield if you bought 5 years ago. Shows dividend growth impact over time.
Consecutive years of dividend payments. 25+ years = Dividend Aristocrat.
Proprietary score (0-100) combining yield, growth, safety and consistency.
Last update: 2026-11-10 02:37 UTC